Status: Recruiting
Avapritinib Rollover Study
The primary objective of the rollover study is to evaluate the long-term safety of avapritinib in participants who have completed a Blueprint Medicines sponsored study (parent study) and continued to benefit from avapritinib.
Participants needed: 60
Trial details
Phase: Phase 4Biological sex: AllType: InterventionalSponsor: Blueprint Medicines CorporationUpdated: Feb 9, 2026Locations: 7
Eligibility criteria
Participated in a Blueprint Medicines sponsored avapritinib clinical study. The... [+5]
Participant is participating in another interventional study. [+2]